"lctotest" brain damage #{149} kernicterus Estimation of BR' binding to serum protein by using Sephadex gel filtration is gaining increased acceptance (1) (2) (3) (4) (5) . Other methods such as dialysis (6), ultrafiltration (7), and electrophoresis (8) determine the limit of the maximal capacity of serum albumin to bind BR, whereas the Sephadex method detects the presence in serum of BR that is loosely bound to protein. LBB can be detected in serum at BR concentrations and B/A ratios lower than the 2:1 B/A ratio at which free BR is detected by the other methods (2). By more sophisticated methods such as optical rotatory dispersion (circular dichroism) and spectrofluorometry it has also been demonstrated that BR is bound to albumin at more than one set of binding sites with different binding affinities (9). 
Materials and Methods
Cord blood and blood from normal adults was allowed to clot at room temperature and serum was separated by centrifugation. Pools of cord blood serum were derived from approximately 10 specimens each and pools of adult serum from five subjects each. Sera that appeared hemolytic were discarded.
The pools were kept at 4 #{176}C until used. Twelve pools of cord blood serum and nine of adult serum were investigated.
Fresh solutions of crystalline BR (Nutritional Biochemicals Corp., Cleveland, Ohio; certified by the American College of Pathologists) were prepared in NaOH solution (0.1 mol/liter) and ranged in concentration from 2.2-15.4 mg/100 ml. Immediately after preparation, 50 l of each solution was added to 1.0-ml aliquots of serum and 50 l of HC1 (0.1 mol/liter) was then added to neutralize the NaOH added. The final BR concentrations of the model jaundiced sera ranged from 10-70 mg/100 ml. From each solution 0.2 ml was removed for determination of BR (14) and then 0.9 ml of phosphate buffer (0.067 mol/liter, pH 7.45) was added to the remainder to give a final pH of 7.4-7.5. (This pH range was selected to reflect the pH in vivo at 37 #{176}C). For the Sephadex gel filtration specially prepared small columns (Ames-Yissum Co., Jerusalem), packed with 2 ml of "Sephadex G-25, fine" (Pharmacia, Upsala) equilibrated with the phosphate buffer were used.
For the qualitative test, 0.4 ml of the final serum-BR solution was applied to the column and after the solution had entered into the Sephadex bed the wall of the column was cleansed of any traces of BR-containing solution by use of a cotton swab. The column was then washed with 3 ml of the phosphate buffer and the last of the eluate tested for completeness of elution of serum protein with sulfosalicylic acid (20 g/100 ml). A solution of p-nitrobenzene diazonium p-toluene sulfonate ("Ictotest," Ames Co., Elkhart, md.), prepared by dissolving a tablet of the reagent in 1.5 ml of the phosphate buffer, was then run through the column. When LBB was adsorbed from serum by Sephadex, addition of the reagent resulted in the appearance of a blue band, which increased in intensity as it passed down the column. The intensity of the band was assessed when it reached the middle of the column. In cases in which the blue band was particularly intense it appeared against a wider reddish background. When this reddish background was present the staining was classified as ++, when only a blue band appeared staining was classified as +, and if no definite blue color developed the test was classified as negative.
In the quantitative test previously described (13), 1.4 ml of the final serum-BR solutions were applied to the column and eluted with the phosphate buffer until the eluate was protein-free. Any BR retained by the column was then eluted with about 5 ml of NaOH (0.1 mol/liter) and collected into 2 ml of a mixture of citric acid (0.5 mol/liter) and ascorbic acid (0.1 mol/liter).
The total eluate of this second elution was extracted with 1.5 ml of chloroform and kept in the dark for several hours, to allow the BRcontaining chloroform layer to separate completely. The absorbance of the chloroform layer was then measured at 450 nm (Amax of BR in chloroform) in an Optica CF4 spectrophotometer (Optica, s.P.A., Milan). One milligram of BR in 100 ml of chloroform, in a cuvette with a 1-cm lightpath, gave a reading of 0.980
The BR concentration at which LBB starts to be present in the serum was determined as described previously (13) . Above a certain BR concentration in serum, the amount of BR in the eluate increases markedly and almost linearly. The regression line relating the BR concentration of the BR-serum solution applied on the column to that in the corresponding eluate is calculated by the method of least squares and the BR concentration at which this line intersects the abscissa is taken as the "critical concentration" above which LBB is present in the given serum.
Albumin was determined, before BR was added to the serum pools, by an acid-alcohol precipitation method (15). Results were corrected for dilution made by the subsequent additions of BR and HC1. In the calculation of the B/A ratio the 1:1 mol ratio was taken as 8.5 mg of BR per gram of albumin.
Results
At low BR concentrations of model jaundiced serum, no measurable BR was found in the chloroform extract of the eluate and the qualitative test was negative, as in the typical experiment illustrated in Figure 1 . After a certain BR concentration was reached, the BR concentration in the eluate increased, and near the "critical concentration" at which the regression line relating the concentration of the BR in serum to that in the eluate intersected the abscissa, the qualitative test first showed + staining of the column, and at higher serum BR concentrations + + staining. The "critical concentration" thus derived is that above which LBB is expected to be present in serum. The BR concentration and B/A ratio of 19 out of 21 model sera in which there was no staining of the column (negative qualitative test) were below those at which LBB was calculated to be present in serum by the quantitative method (Figure 2) . Thus, the highest BR concentration for each serum pool at which the column still stained negative was on the average 3.78 mg/100 ml lower than the "critical concentrations" of the respective pools, and the correlation between the BR concentrations of these negative staining sera and the respective "critical concentrations" was highly significant (Table 1) . Similar relationships held for the B/A ratios ( Table 1) . The lowest BR concentrations with + staining for each pool were scattered around the "critical BR concentration" at which LBB was calculated to be present, in the same pools. There was a highly signifi- cant correlation between the lowest BR concentrations (and B/A ratios) at which each serum pool gave a + result by the qualitative test and the "critical BR concentrations"
(and "critical B/A ratios") derived from the quantitative test (Table 1 ). The mean difference between the BR concentrations at which sera first gave + staining and the corresponding "critical concentrations" was only -0.15 mg/100 ml ( Table 1) . With regard to + + staining of the column, there was a large difference between the lowest BR concentrations giving this degree of staining and the "critical BR concentrations," which averaged 9.98 mg/100 ml and 0.33 (B/A ratio).
While differences were found in the absolute values of BR and B/A ratios at which LBB was found to be present in serum of infants and adults, there was no difference in the correlation of the two methods in the case of either type of serum.
The qualitative estimation of LBB evidently correlates well with the quantitative method. There was a highly significant correlation between each group of serum pools identified as negative, +, and ++ by the qualitative method, and the "critical concentrations" of BR at which LBB was estimated to be present in serum by using the quantitative method. In only two of 21 serum pools that gave a negative #{149} qualitative result was LBB calculated to be present from the quantitative method. However, in these two negative sera the BR concentration was so close to the "critical concentration"
as to be within the range of the error of the determination.
The column may stain + at concentrations lower than the value at which LBB is demonstrated by the quantitative method. This may be due to the fact that with the latter method, the "critical BR concentration" is arbitrarily defined from the regression line relating BR concentration in serum and in the corresponding eluate, and by this method the lowest BR concentration at which LBB is present may be overestimated.
For the Sephadex might itself bind BR at serum BR concentrations just below those at which the first BR binding site of albumin is saturated, yielding small quantities of BR into the chloroform eluate, quantities so small as not yet to be linearly related to the BR concentrations of the corresponding sera. Indeed, this area of the curve relating BR concentration in the eluate to that in the corresponding serum tends to be curvilinear (to be published), so that by treating the regression as linear, the "critical concentration"
derived from the regression line (intersection with the abscissa) is overestimated. Thus, the qualitative test may actually be a better index of the true state of BR binding at lower BR concentrations than the quantitative test as described.
It thus appears that the qualitative test may be a reliable indicator of the presence or absence of LBB in a given serum. It requires less than 30 mm to perform, only small aliquots of serum are required and special instrumentation is not needed. Furthermore, parallel determination of BR and albumin is not required, as with the quantitative method. Also, in the latter test the results can only be evaluated by drawing the regression line, either from calculations or by inspection.
It has been proposed that by adding BR in appropriate amounts to serum the concentration of BR at which LBB would be present in a given serum can be estimated (4). For this purpose, a test kit has been developed and is being tested clinically. With this kit, infant or cord blood serum can be tested for LBB before and, if negative, after addition of increments of BR. The clinical importance of these estimations has also been emphasized by Schiff et al.
(5).
In a previous study in 68 jaundiced infants, the sera of all seven infants with kernicterus gave + + staining of the column (4). This degree of staining thus indicates that the infant is most likely to have brain damage. It may well be that infants with only + staining are those who are in more or less imminent danger of developing brain damage, and that they are all potential candidates for intensive preventive measures. This does not apply to the rare case in which more than minimal amounts of directreacting BR are present in the serum, since directreacting BR may stain the Sephadex column even at low total BR concentrations (A. Priolisi, personal communication).
Therefore, in cases whose sera give positive staining, the direct diazo reaction should be performed to evaluate correctly the clinical status of the infant.
